Ex-FDA interim chief Giroir rejoins biotech world with eyes on $50M fundraising for new infectious disease company.
- Altesa Biosciences To Initiate Clinical Trials Of Promising Antiviral
- Altesa Biosciences Recognizes Co-Founder and Partner for Major NIH Research Grant to Discover New Antiviral Drugs
- Wall Street Journal
- Altesa BioSciences, Inc., Launches Operations to Develop, Commercialize Drugs for Respiratory Viruses and Global Viral Threats